Description | The anti-influenza A virus mAb exhibited the strongest H7 HA binding capacity. It effectively prevented influenza A H7N9 viral infection when used at antibody concentrations ranging from 200 to 25 μg/ml. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | Influenza A virus (IAV) |
Isotype | IgG1 |
Expression Species | HEK293F or CHO cell line |
Conjugation | Unconjugated |
Purity | >95% |
Endotoxin | <1 EU/mg |
Form | Liquid |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
Application | ELISA; Neut |
Application Notes | Function assay: The concentrations ranging from 200 to 25 μg/ml to prevent influenza A H7N9 viral infection. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | IAV H7N9 |
Alternative Name | Influenza A virus H7N9; H7N9; Influenza A virus |
Research Area | Microbiology |